Support of existing NHSBT Multi-functional Apheresis systems

The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. TAS treatments provided using multi-functional apheresis technology include: Collection Procedures: Peripheral Blood Stem Cell Collection & Lymphocyte Collection; Exchange Procedures: Plasma Exchange and Automated Red Cell Exchange; Depletion Procedures: White Cell Depletion, Platelet Depletion and Bone Marrow processing.

The requirement of this procurement is for the supply of consumables and maintenance in support of the existing TerumoBCT Spectra Optia machines.

This Framework Agreement is for a period of 2 years with two 1-year options to extend. It is the intension of NHSBT to award a Framework Agreement for these requirements by August 2021. The following contracting authorities will be able to purchase against the Framework Agreement: any NHS Authority or Trust, Welsh Blood Service and Scottish National Blood Transfusion Service.